Solara Scales Up: 20 Crore Expansion Planned for Karnataka API Unit

Solara Active Pharma Sciences Private Limited, a leading pharmaceutical company, is set to embark on a significant expansion project at the Baikampady Industrial Area in Dakshina Kannada, Karnataka. The expansion, estimated at 20 crores, aims to bolster the production of bulk drugs and intermediates, catering to the growing demand in the pharmaceutical sector.

The project entails an ambitious plan to produce 674,520 kilograms of bulk drugs and intermediates, reinforcing Solara Active Pharma Sciences' position as a key player in the industry. This move aligns with the company's commitment to meeting the evolving needs of the healthcare market while ensuring quality and reliability in its products.

Located in a strategic industrial hub, the Baikampady Industrial Area provides Solara Active Pharma Sciences with a conducive environment for expansion. Its proximity to key transportation networks and infrastructure facilities enhances logistical efficiency, facilitating seamless operations for the company.

The expansion project is expected to generate employment opportunities in the region, contributing to economic growth and development. With its focus on innovation and sustainable practices, Solara Active Pharma Sciences aims to make a positive impact on the local community while advancing its business objectives.

News by Rahul Yelligetti